Standard BioTools ROE 2010-2024 | LAB
Current and historical return on equity (ROE) values for Standard BioTools (LAB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Standard BioTools ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-06-30 |
$-0.17B |
$0.51B |
-46.15% |
| 2024-03-31 |
$-0.14B |
$0.58B |
-48.66% |
| 2023-12-31 |
$-0.08B |
$0.16B |
-39.74% |
| 2023-09-30 |
$-0.08B |
$0.18B |
-36.98% |
| 2023-06-30 |
$-0.08B |
$0.20B |
-37.71% |
| 2023-03-31 |
$-0.13B |
$0.21B |
-54.19% |
| 2022-12-31 |
$-0.19B |
$0.23B |
-98.06% |
| 2022-09-30 |
$-0.18B |
$0.25B |
-111.25% |
| 2022-06-30 |
$-0.16B |
$0.27B |
-133.06% |
| 2022-03-31 |
$-0.12B |
$0.02B |
-142.77% |
| 2021-12-31 |
$-0.06B |
$0.10B |
-55.40% |
| 2021-09-30 |
$-0.07B |
$0.10B |
-57.87% |
| 2021-06-30 |
$-0.06B |
$0.11B |
-45.89% |
| 2021-03-31 |
$-0.06B |
$0.12B |
-40.95% |
| 2020-12-31 |
$-0.05B |
$0.14B |
-37.52% |
| 2020-09-30 |
$-0.05B |
$0.15B |
-33.10% |
| 2020-06-30 |
$-0.06B |
$0.13B |
-37.23% |
| 2020-03-31 |
$-0.06B |
$0.14B |
-35.50% |
| 2019-12-31 |
$-0.07B |
$0.15B |
-38.69% |
| 2019-09-30 |
$-0.07B |
$0.16B |
-45.42% |
| 2019-06-30 |
$-0.07B |
$0.17B |
-61.47% |
| 2019-03-31 |
$-0.07B |
$0.18B |
-91.32% |
| 2018-12-31 |
$-0.06B |
$0.07B |
-132.58% |
| 2018-09-30 |
$-0.05B |
$0.02B |
-157.66% |
| 2018-06-30 |
$-0.06B |
$0.04B |
-142.86% |
| 2018-03-31 |
$-0.06B |
$0.05B |
-156.64% |
| 2017-12-31 |
$-0.06B |
$0.03B |
-180.45% |
| 2017-09-30 |
$-0.07B |
$0.04B |
-175.48% |
| 2017-06-30 |
$-0.07B |
$0.02B |
-156.52% |
| 2017-03-31 |
$-0.07B |
$0.04B |
-121.31% |
| 2016-12-31 |
$-0.08B |
$0.05B |
-101.32% |
| 2016-09-30 |
$-0.07B |
$0.07B |
-78.69% |
| 2016-06-30 |
$-0.06B |
$0.08B |
-57.82% |
| 2016-03-31 |
$-0.06B |
$0.10B |
-48.41% |
| 2015-12-31 |
$-0.05B |
$0.12B |
-41.25% |
| 2015-09-30 |
$-0.05B |
$0.12B |
-37.16% |
| 2015-06-30 |
$-0.06B |
$0.13B |
-38.62% |
| 2015-03-31 |
$-0.05B |
$0.14B |
-35.47% |
| 2014-12-31 |
$-0.05B |
$0.15B |
-33.44% |
| 2014-09-30 |
$-0.05B |
$0.16B |
-32.41% |
| 2014-06-30 |
$-0.04B |
$0.16B |
-28.35% |
| 2014-03-31 |
$-0.03B |
$0.17B |
-24.45% |
| 2013-12-31 |
$-0.02B |
$0.10B |
-17.39% |
| 2013-09-30 |
$-0.02B |
$0.10B |
-16.16% |
| 2013-06-30 |
$-0.02B |
$0.10B |
-15.92% |
| 2013-03-31 |
$-0.02B |
$0.10B |
-19.26% |
| 2012-12-31 |
$-0.02B |
$0.10B |
-26.23% |
| 2012-09-30 |
$-0.02B |
$0.10B |
-29.12% |
| 2012-06-30 |
$-0.02B |
$0.05B |
-35.02% |
| 2012-03-31 |
$-0.02B |
$0.05B |
-36.52% |
| 2011-12-31 |
$-0.03B |
$0.06B |
-50.20% |
| 2011-09-30 |
$-0.03B |
$0.06B |
-12400.00% |
| 2011-06-30 |
$-0.03B |
$0.06B |
200.00% |
| 2011-03-31 |
$-0.03B |
$0.07B |
91.80% |
| 2010-12-31 |
$-0.02B |
$-0.19B |
35.60% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.830B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
